(Q50183052)

26 February 2018

title

The Sunnybrook Gallstone Study: a double-blind controlled trial of chenodeoxycholic acid for gallstone dissolution. (English)

1 reference

26 February 2018

author name string

Fisher MM

1

1 reference

26 February 2018

Roberts EA

2

1 reference

26 February 2018

Rosen IE

3

1 reference

26 February 2018

Shapero TF

4

1 reference

26 February 2018

Sutherland LR

5

1 reference

26 February 2018

Davies RS

6

1 reference

26 February 2018

Bacchus R

7

1 reference

26 February 2018

Lee SV

8

1 reference

26 February 2018

language of work or name

English

0 references

publication date

1 January 1985

1 reference

26 February 2018

published in

Hepatology

1 reference

26 February 2018

volume

5

1 reference

26 February 2018

issue

1

1 reference

26 February 2018

page(s)

102-107

1 reference

26 February 2018

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

Effect of gallstone-dissolution therapy on human liver structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

Design and methodological considerations in the National Cooperative Gallstone Study: A multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Dissolution of cholesterol gallstones by ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Treatment of patients with gallstones with chenodeoxycholic acid (author's transl)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Chenotherapy for gallstone dissolution. I. Efficacy and safety

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Gallstone dissolution with chenodeoxycholic acid. A clinical study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Oral cholelitholysis--cheno versus urso: Japanese experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Sounding Board. An optimistic view of the National Cooperative Gallstone Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

The value of radiology in predicting gallstone type when selecting patients for medical treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Pigment vs cholesterol cholelithiasis: Clinical and epidemiological aspects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Low-dose chenodeoxycholic acid for gallstone dissolution: a randomized trial in poor operative risk patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Effect of chenodeoxycholic acid on liver structure and function in man: a stereological and biochemical study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050121

7 January 2021

Identifiers

DOI

10.1002/HEP.1840050121

1 reference

26 February 2018

1 reference

26 February 2018